Digital Pathology Market Worth $437 Million by 2018 - New Report by MarketsandMarkets

The high growth for the digital pathology market can be attributed to the favorable reimbursement scenario in U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada in North America. http://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.).

(PRWEB) August 07, 2014

The "Digital Pathology Market Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & Whole Slide Image Storage - Global Forecasts & Trends to 2018"analyzes and studies the major market drivers and restraints in geographies such as North America, Europe, Asia, and the Rest of the World (RoW).

Browse 78 market data tables, 17 figures spread through 252 pages and in-depth TOC on “Digital Pathology Market Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & Whole Slide Image Storage - Global Forecasts & Trends to 2018.”

This report studies the global digital pathology market over the forecast period of 2013 to 2018. The market was estimated at $250.2 million in 2013 and is expected to reach $437 million by 2018, growing at a CAGR of 11.8% from 2013 to 2018.

For More Inquiry: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=844

This report covers the definition, description, and forecast of the digital pathology market in terms of products and applications. Based on products, the digital pathology market comprises of scanners, analytics, storage, and communication.

The application market is categorized into human and animal pathology. Human pathology is segmented into pharmaceutical and biotech companies, hospitals and reference laboratories, and training and education centers, while animal pathology is segmented into pharmaceutical and biotechnology companies, contract research organizations, and academic and government research institutes.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=844

The report categorizes overall digital pathology market on the basis of products, applications, and geographies. Based on products, the market comprises of scanners, analytics, storage, and communication. Based on applications, the market is categorized into human and animal pathology. Human pathology is segmented into pharmaceutical and biotechnology companies, hospitals and reference laboratories, and training and education centers, while animal pathology is segmented into pharmaceutical and biotechnology companies, contract research organizations, and academic and government research institutes.

North America accounted for the largest share of the global digital pathology market, followed by Europe and Asia. The dominance of the North American market can be attributed to the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, the Asian market is expected to experience the highest growth in the digital pathology market. The high growth in this region can be attributed to the rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the use of digital pathology to improve the quality of cancer diagnosis.

Some of the prominent players in the global digital pathology market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.).

Browse Related Reports:
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html

Digital X-ray Market by Application (Mammography, Dental, Chest Imaging), Technology (Computes, Direct), Portability (Floor to ceiling mounted, Ceiling mounted, Handheld), End User, Price segments, Flat panel detectors, Software - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/digital-x-ray-market-1164.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog: http://mnmblog.org/market-research/healthcare/healthcareit
Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets


Contact